3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
46
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Myelodysplastic Syndromes
26
Recurrence
19
Multiple Myeloma
19
Lymphoma, Non-Hodgkin
15
Lymphoma, B-Cell
14
Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Pancreatic Neoplasms
10
Myeloproliferative Disorders
10
Melanoma
10
Burkitt Lymphoma
10
Leukemia
9
Hodgkin Disease
9
Stomach Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
7
Leukemia, Biphenotypic, Acute
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasm Metastasis
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Juvenile
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelin-positive Advanced Refractory Solid Tumors
×
fludarabine
×
90 days
×
Clear all
No trials found.